Ipamorelin Peptide 5mg

Ipamorelin Peptide 5mg: Product Overview

Ipamorelin Peptide 5mg is a synthetic pentapeptide classified as a selective growth hormone secretagogue. Also known by its development code NNC 26-0161, Ipamorelin has been investigated for its ability to stimulate growth hormone (GH) release through interactions with the ghrelin receptor, GHS-R1a.

Unlike synthetic growth hormone itself, Ipamorelin belongs to a class of compounds that influence endogenous hormone secretion. The 5mg designation refers to the stated peptide quantity in this product listing and does not represent an administration dose.

Ipamorelin 5mg Product Specifications

• Product Name: Ipamorelin Peptide 5mg
• Alternative Name: NNC 26-0161
• Peptide Type: Synthetic pentapeptide
• Classification: Growth hormone secretagogue
• Listed Quantity: 5mg
• CAS Number: 170851-70-4 (free base)
• Molecular Formula: C38H49N9O5
• Molecular Weight: Approximately 711.9 g/mol (free base)
• Peptide Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
• Category: Research Peptides

These molecular specifications describe Ipamorelin free base. Salt forms, including Ipamorelin acetate, can have different compositional characteristics. The supplied form should be verified using the product label and available documentation.

What Is Ipamorelin Peptide?

Ipamorelin is a synthetic five-amino-acid peptide developed through research into growth hormone-releasing compounds. It is part of the growth hormone secretagogue family and acts through the growth hormone secretagogue receptor rather than directly replacing growth hormone.

Scientific investigations have focused on the compound's receptor selectivity, endocrine effects and relationship with the growth hormone signaling system.

Ipamorelin is distinct from GHRP-2, GHRP-6 and growth hormone-releasing hormone analogs, although these compounds are frequently discussed within the same research category.

Ipamorelin Mechanism of Action

Ipamorelin acts as an agonist of the growth hormone secretagogue receptor GHS-R1a, also known as the ghrelin receptor. Activation of this receptor can stimulate growth hormone secretion from the anterior pituitary gland.

Experimental research has described Ipamorelin as relatively selective for growth hormone release compared with certain earlier growth hormone-releasing peptides.

This receptor-mediated activity distinguishes Ipamorelin from recombinant human growth hormone (HGH), which supplies the hormone directly rather than stimulating its release.

Ipamorelin Peptide Research Background

Research involving Ipamorelin has examined growth hormone secretion, ghrelin receptor signaling and endocrine responses. Early experimental studies evaluated the compound's hormone-releasing activity and selectivity.

Other investigations have explored gastrointestinal motility and related physiological processes. Clinical evidence remains limited, and research findings do not establish the safety or effectiveness of independently supplied Ipamorelin peptide products for medical or performance-related applications.

Reported biological effects depend on experimental conditions, formulation, study population and measured endpoints.

Ipamorelin vs GHRP-2 and GHRP-6

Ipamorelin, GHRP-2 and GHRP-6 belong to the broader category of growth hormone secretagogues, but they have different molecular structures and pharmacological characteristics.

• Ipamorelin: A synthetic pentapeptide investigated for relatively selective growth hormone release.
• GHRP-2: A synthetic growth hormone-releasing peptide with a different amino acid sequence and endocrine activity profile.
• GHRP-6: Another growth hormone secretagogue studied for its receptor interactions and effects on GH secretion and appetite-related signaling.

These peptides should not be treated as interchangeable. Differences in receptor activity, experimental findings and product specifications require compound-specific evaluation.

Ipamorelin vs Human Growth Hormone (HGH)

Ipamorelin and recombinant human growth hormone are fundamentally different substances.

Ipamorelin is a small synthetic peptide that interacts with receptors involved in endogenous growth hormone release. Recombinant HGH is a manufactured version of the human growth hormone protein itself.

Their molecular structures, biological mechanisms and research applications differ. Findings involving one compound cannot automatically be applied to the other.

Ipamorelin 5mg Packaging and Documentation

The Ipamorelin Peptide 5mg listing identifies a stated quantity of peptide material. Product evaluation should include verification of the supplied label, chemical form, declared quantity and available batch-specific documentation.

Relevant documentation may include peptide identity testing, analytical purity information and formulation-specific storage instructions. General chemical reference data does not establish the purity or quality of an individual product batch.